Programming tissue-sensing T cells that deliver therapies to the brain
To engineer cells that can specifically target the central nervous system (CNS), we identified extracellular CNS-specific antigens, including components of the CNS extracellular matrix and surface molecules expressed on neurons or glial cells. Synthetic Notch receptors engineered to detect these antigens were used to program T cells to induce the expression of diverse payloads only in the brain. CNS-targeted T cells that induced chimeric antigen receptor expression efficiently cleared primary and secondary brain tumors without harming cross-reactive cells outside of the brain. Conversely, CNS-targeted cells that locally delivered the immunosuppressive cytokine interleukin-10 ameliorated symptoms in a mouse model of neuroinflammation. Tissue-sensing cells represent a strategy for addressing diverse disorders in an anatomically targeted manner.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Immunology
3 publications, 6.38%
|
|
|
Science
2 publications, 4.26%
|
|
|
Molecular Therapy
2 publications, 4.26%
|
|
|
npj Precision Oncology
2 publications, 4.26%
|
|
|
Journal of Translational Medicine
2 publications, 4.26%
|
|
|
Advanced Science
2 publications, 4.26%
|
|
|
Biomaterials
2 publications, 4.26%
|
|
|
Cell Reports Medicine
2 publications, 4.26%
|
|
|
Nature
1 publication, 2.13%
|
|
|
Materials Today Bio
1 publication, 2.13%
|
|
|
Nature Reviews Drug Discovery
1 publication, 2.13%
|
|
|
Trends in Immunology
1 publication, 2.13%
|
|
|
InFo Neurologie + Psychiatrie
1 publication, 2.13%
|
|
|
Cancer Cell
1 publication, 2.13%
|
|
|
Seminars in Immunology
1 publication, 2.13%
|
|
|
American Journal of Physiology - Cell Physiology
1 publication, 2.13%
|
|
|
Annals of Neurology
1 publication, 2.13%
|
|
|
Science advances
1 publication, 2.13%
|
|
|
European Journal of Pharmaceutics and Biopharmaceutics
1 publication, 2.13%
|
|
|
Brain, Behavior, and Immunity
1 publication, 2.13%
|
|
|
Advanced Materials
1 publication, 2.13%
|
|
|
Cancer Communications
1 publication, 2.13%
|
|
|
Medicina
1 publication, 2.13%
|
|
|
Discover Oncology
1 publication, 2.13%
|
|
|
Human Vaccines and Immunotherapeutics
1 publication, 2.13%
|
|
|
Regenerative Engineering and Translational Medicine
1 publication, 2.13%
|
|
|
Journal of Controlled Release
1 publication, 2.13%
|
|
|
Nature Reviews Immunology
1 publication, 2.13%
|
|
|
Seminars in Oncology
1 publication, 2.13%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 31.91%
|
|
|
Springer Nature
11 publications, 23.4%
|
|
|
Wiley
5 publications, 10.64%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 8.51%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 6.38%
|
|
|
Frontiers Media S.A.
3 publications, 6.38%
|
|
|
American Physiological Society
1 publication, 2.13%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 2.13%
|
|
|
MDPI
1 publication, 2.13%
|
|
|
Taylor & Francis
1 publication, 2.13%
|
|
|
AIP Publishing
1 publication, 2.13%
|
|
|
Public Library of Science (PLoS)
1 publication, 2.13%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.